16.02.2018
- US drugmaker Merck & Co. has said it will halt its APECS randomized, placebo-controlled, parallel-group, double-blind Phase 3 clinical trial evaluating the efficacy and safety of...
12.04.2016
- Allergan Pharmaceuticals International, a wholly owned subsidiary of Ireland-based Allergan, has entered a definitive agreement with British biotech firm Heptares to license...
29.07.2015
- A new experimental Alzheimer’s drug, solanezumab, developed by Eli Lilly has raised hopes for a breakthrough in the treatment of the disease. The progress was reported at the...
17.07.2014
- Swiss drugmaker Roche said its experimental Alzheimer's drug failed to meet its main goals in a mid-stage study, a result likely to bolster the belief that drugs need to be given...
